Elemer Piros Stock Analyst Profile - LUCID CAPITAL MARKETS Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Elemer Piros

    Stock Analyst at LUCID CAPITAL MARKETS

    (3.7)
    # 2384
    Out of 5,477 analysts
    143
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Financial Services
    Top Industries:
    Biotechnology Medical - Care Facilities Drug Manufacturers - Specialty & Generic
    49 Stocks
    Name Action PT Current % Upside Ratings Updated
    BTAI BioXcel Therapeutics
    Reiterates: Buy
    66 66
    		3.39 1846.9% 2 Jul 15, 2025
    FBLG FibroBiologics
    Initiates Coverage On: Buy
    12
    		0.56 2042.86% 1 Dec 12, 2024
    THAR Tharimmune
    Initiates Coverage On: Buy
    17
    		3.13 443.13% 1 Dec 6, 2024
    QNCX Quince Therapeutics
    Initiates Coverage On: Buy
    11
    		1.58 596.2% 1 Oct 29, 2024
    MNPR Monopar Therapeutics
    Initiates Coverage On: Buy
    50
    		47.66 4.91% 6 Oct 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    17
    		1.66 924.1% 1 Sep 30, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    22
    		n/a n/a 1 Aug 19, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    107 107
    		2.16 4853.7% 1 Aug 8, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    14 14
    		2.36 493.22% 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    67 67
    		2.38 2715.13% 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    43
    		3.93 994.15% 1 Jun 21, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    18
    		6.21 189.86% 7 Jun 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12 8
    		1.6 368.75% 3 Sep 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    15 15
    		4.6 226.09% 8 Aug 9, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    21
    		9.65 117.62% 8 Aug 4, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    38
    		5.24 625.19% 9 Aug 3, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    40
    		0.79 4963.29% 2 Jul 10, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    50
    		4.09 1122.49% 5 Jun 30, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    114
    		6.01 1796.84% 3 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    260 200
    		6.18 3136.25% 6 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    23
    		3.41 574.49% 2 May 16, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    33
    		12.46 164.85% 3 Mar 2, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    11
    		1.12 882.14% 2 Feb 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    40
    		25.4 57.48% 7 Apr 14, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    40
    		n/a n/a 3 Jan 4, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    37
    		1.6 2212.5% 1 Dec 1, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    38 32
    		7.28 339.56% 2 Jun 30, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    128 124
    		n/a n/a 7 May 6, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    10
    		n/a n/a 1 Apr 28, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    77
    		18.04 326.83% 2 Dec 23, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    70
    		1.91 3564.92% 1 Oct 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    240
    		n/a n/a 1 Sep 17, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 5 Sep 8, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    21 24
    		1.3 1746.15% 4 May 28, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    225 75
    		n/a n/a 2 May 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    24 50
    		29.72 68.24% 5 Nov 19, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Overweight
    33
    		5.56 493.53% 2 Oct 22, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    191 186
    		19 878.95% 4 Aug 8, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Overweight
    n/a
    		n/a n/a 3 Jul 11, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    26
    		4.2 519.05% 3 May 6, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    80 115
    		n/a n/a 3 Feb 25, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    21
    		n/a n/a 1 Nov 7, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    28
    		144.36 -80.6% 1 Sep 11, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    14 17
    		n/a n/a 2 Aug 9, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    70 65
    		11.1 485.59% 2 Jun 13, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    525 850
    		6.75 12492.59% 1 Oct 12, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    204 84
    		n/a n/a 2 Sep 22, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    29
    		n/a n/a 1 Jul 20, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    35 21
    		12.77 64.45% 2 Jul 12, 2017